Results from a phase I study of 4- l -[131I]iodo-phenylalanine ([ 131 I]IPA) with external radiation therapy in patients with recurrent glioblastoma (IPAX-1).
Josef PichlerTatjana Traub-WeidingerKurt SpieglLarisa ImamovicArthur J A T BraatTom Jan SnijdersJoost J C VerhoeffPatrick FlamenLibuse TauchmanovaColin HaywardAndreas KlugePublished in: Neuro-oncology advances (2024)
I]IPA plus XRT were associated with acceptable tolerability and specific tumor targeting in patients with recurrent GBM, warranting further investigation.